BYFC · Broadway Financial Corp De · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-28 | Carew Tina |
EVP, CLO & Corporate Secretary |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment is being filed to update the grant date in this Note 1 to the Form 4 due to a clerical error. Restricted Stock granted July 28, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
4,921 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
3 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
574 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
2 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
1 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
2,353 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
97 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
202 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
263 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
5 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
4,887 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
1 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
5 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
107 |
| 2026-05-26 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
100 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
30 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
300 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
200 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
568 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
200 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
100 |
| 2026-05-22 | Bradshaw Wayne-Kent A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
2 |
| 2026-05-07 | Driver John |
Director |
Sell↓
|
Common Stock
|
6,500 |
| 2026-03-02 | Jennings William Justin |
EVP, Chief Deposit Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
4,458 |
| 2026-03-02 | DAVIDSON ROBERT C JR |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2026-03-02 | Allen John Anthony |
EVP, Chief Banking Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
7,833 |
| 2026-03-02 | Hentges Mary |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. |
Common Stock
|
2,675 |
| 2026-03-02 | Bradshaw Wayne-Kent A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'. |
Common Stock
|
2,675 |
| 2026-03-02 | Washington LaShanya Demetrice |
EVP, Chief Credit Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. Shares Amount adjusted for Reverse Stock split effective October 31, 2023. |
Common Stock
|
6,480 |
| 2026-03-02 | Donovan Mary Ann |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2026-03-02 | JOHNS MARIE C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2026-03-02 | Argrett Brian E |
Director, President/CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 02, 2026, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months. Shares amount adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
23,793 |
| 2026-03-02 | Ross Dutch C. III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2026-03-02 | McGrady David J. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2026-03-02 | Ibrahim Zack |
EVP/Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
11,521 |
| 2026-03-02 | Driver John |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,675 |
| 2025-10-15 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-14 | Jennings William Justin |
EVP, Chief Deposit Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted October 14, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
4,936 |
| 2025-10-14 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-13 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-10 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-09 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-08 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-07 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-06 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-03 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-10-02 | DAVIDSON ROBERT C JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing. |
Common Stock
|
1,000 |
| 2025-05-28 | Allen John Anthony |
EVP, Chief Banking Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted May 28, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. |
Common Stock
|
8,183 |
| 2025-03-24 | McCloud Ruth |
EVP/COO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023. Shares amount adjusted for reverse Stock split effective October 31, 2023 |
Common Stock
|
5,498 |
| 2025-03-24 | DAVIDSON ROBERT C JR |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents Award of Unrestricted stock issued on March 24, 2025 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation. The amount of securities adjusted for reverse stock split effective October 31, 2023. |
Common Stock
|
2,904 |